Isotretinoin Sandoz

Isotretinoin, the active ingredient in Isotretinoin Sandoz, is a retinoid presented as an oral capsule for oral use. It is prescribed for severe nodular acne and other forms of acne vulgaris in patients who have not responded to conventional therapies.

GNH USA supplies Isotretinoin Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Isotretinoin is a retinoid that targets the pilosebaceous unit in severe acne.

- Severe nodular acne: reduces existing lesions and prevents formation of new nodules. - Acne vulgaris: decreases inflammatory lesions and comedones, improving skin appearance. - Cystic acne: helps resolve deep, painful cysts and reduces scarring risk.

Isotretinoin may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Dry skin and mucous membranes. - Cheilitis (cracked lips). - Xerosis (dry eyes). - Photosensitivity. - Elevated liver enzymes. - Hypertriglyceridemia.

Serious or Rare Side Effects: - Severe depression or suicidal ideation. - Inflammatory bowel disease. - Teratogenic birth defects. - Pancreatitis. - Severe hyperlipidemia. - Pseudotumor cerebri (increased intracranial pressure).

Before initiating therapy, clinicians should assess patient suitability and monitor key parameters.

- Teratogenicity: avoid use in pregnancy; require effective contraception. - Liver function: monitor transaminases regularly. - Lipid profile: check triglycerides and cholesterol before and during treatment. - Vitamin A: do not combine with other retinoids or high‑dose vitamin A supplements. - Mood changes: observe for signs of depression or suicidal thoughts. - Store below 25°C: keep in the original pack, protect from moisture.

Isotretinoin can interact with several medicines, requiring careful management.

Major Interactions (Avoid): - Tetracycline antibiotics: reduced efficacy of both agents. - Vitamin A supplements: risk of cumulative toxicity. - Systemic corticosteroids: increased risk of pseudotumor cerebri.

Moderate Interactions (Monitor Closely): - Oral contraceptives: possible reduced contraceptive effectiveness. - Anticoagulants (e.g., warfarin): may alter INR values. - Topical retinoids: heightened skin irritation risk.